Top Melanoma Treatment Providers in London

• Multiple tertiary NHS teaching hospitals (e.g., Chelsea & Westminster Hospital, Guy’s and St Thomas’, UCLH)
• Extensive private hospital network (HCA Healthcare UK, The London Clinic)
• Internationally recognised dermatology and plastic surgery consultants.

• Highly mature and saturated
• Internationally competitive.

• Remove the primary melanoma completely so it doesnt come back locally.
• Reduce risk of spread to lymph nodes or other organs.
• Control melanoma that has already spread to prolong life and manage symptoms.
• Use systemic treatments like immunotherapy to train the immune system to attack melanoma cells.
• Tailor the plan to your overall health and minimise side effects through multidisciplinary discussion.

Medical & Non-Surgical Approaches

• Surgery is the mainstay for early melanoma; non-surgical alternatives like imiquimod cream may be used for very early or superficial disease in selected cases.
• Radiotherapy is sometimes added for local control where surgery isnt option.
• Systemic options like immunotherapy or targeted drugs arent alternative in the usual sense but are evidence-based treatments for spread or high-risk disease; they work differently from surgery by acting systemically.
• There isnt high-quality evidence for complementary therapies curing melanoma; they may be supportive for wellbeing but not a substitute for evidence-based care.

Pros of Melanoma-treatment Treatment

• Early stage surgery can be curative and very effective.
• Modern immunotherapies have improved outcomes for advanced melanoma.
• Targeted drugs can slow or halt cancer growth by focusing on specific tumour pathways.
• Follow-up and surveillance help catch recurrence early.

Cons of Melanoma-treatment Treatment

• Side effects from immunotherapy or targeted drugs can be serious and long-lasting.
• Advanced melanoma treatment isnt guaranteed and sometimes slows rather than cures.
• Radiotherapy and chemotherapy can cause fatigue, nausea and other systemic effects.
• Theres emotional and physical burden to undergoing cancer treatment.

• Talk openly with your specialist about expectations, side effects, and timing.
• Ask about scans and tests before treatment starts to get accurate staging.
• Discuss fertility or pregnancy plans if relevant, as some treatments can affect these.
• Get baseline blood tests, organ checks and support networks in place.

• If they do surgical melanoma treatment theyll be a surgical oncologist or dermatologist trained in skin cancer surgery.
• Systemic therapy is managed by medical oncologists experienced in melanoma.
• All teams work within NHS or accredited private hospital governance and have specialist nursing support.

• Anyone diagnosed with melanoma, because treatment is tailored to stage and risk.
• People with early melanoma usually have surgery with high chance of cure.
• Those with stage III or IV disease or high risk may get immunotherapy or targeted therapy.
• Its less about being a candidate and more about staging and shared decision-making with your oncology team.

• If they do surgical melanoma treatment theyll be a surgical oncologist or dermatologist trained in skin cancer surgery.
• Systemic therapy is managed by medical oncologists experienced in melanoma.
• All teams work within NHS or accredited private hospital governance and have specialist nursing support.
• A multidisciplinary team experienced in skin cancer, including surgical oncologists, dermatologists, medical oncologists and specialist nurses.
• Clear communication about options, risks, prognosis and follow-up.
• Access to genetic testing of the tumour (like BRAF status) to personalise systemic therapy.
• Transparent discussion of whether any proposed therapy is on the NHS or why a private option is recommended.
• Support services for emotional and practical care.

• Surgery is the mainstay for early melanoma; non-surgical alternatives like imiquimod cream may be used for very early or superficial disease in selected cases.
• Radiotherapy is sometimes added for local control where surgery isnt option.
• Systemic options like immunotherapy or targeted drugs arent alternative in the usual sense but are evidence-based treatments for spread or high-risk disease; they work differently from surgery by acting systemically.
• There isnt high-quality evidence for complementary therapies curing melanoma; they may be supportive for wellbeing but not a substitute for evidence-based care.